Investor profile
Thor Nagel
Private equity, Venture debt & Bvf Partners, L.P at Biotechnology Value Fund
Thor Nagel works as a Bvf Partners, L.P at Biotechnology Value Fund. The firm's known portfolio counts 17 companies.
Is Thor Nagel a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- BiotechDrug DiscoveryEvergreen FundGenomicsPharmaValue Investing
Contacts
Affiliated funds' portfolios
Bvf Partners, L.P at Biotechnology Value Fund, whose known portfolio counts 17 companies
- Ambrosia Biosciences
- Crossbow Therapeutics
- Palvella Therapeutics
- Expedition Therapeutics
- Verastem Oncology
- Numab
- Rapt Therapeutics
- Septerna
- Cidara Therapeutics
- Merida Biosciences
- Olema Oncology
- Alpha9 Theranostics
- and 5 more
Investor Profile
The listing covers sector Healthcare, and focus areas Biotech, Drug Discovery, Evergreen Fund and Genomics. Startups operating in these areas may find Thor Nagel relevant.
Stage-wise, the deals at Biotechnology Value Fund cluster around Growth, Late-Stage and Seed rounds.
What the affiliated firm has backed is the closest available signal on whether Thor Nagel is worth approaching.
Colleagues at Biotechnology Value Fund
Frequently asked questions
Who is Thor Nagel?
Thor Nagel is a private equity investor and venture debt investor based in San Francisco, California, United States, listed as Bvf Partners, L.P at Biotechnology Value Fund. The known portfolio of that firm counts 17 companies. That portfolio belongs to the firm, not to Thor Nagel personally.
What does Thor Nagel invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Drug Discovery, Evergreen Fund and Genomics. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Thor Nagel invest at?
Biotechnology Value Fund appears in Growth, Late-Stage and Seed rounds across its known deals, and Thor Nagel is listed there as Bvf Partners, L.P. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Thor Nagel listed at?
Thor Nagel is listed as Bvf Partners, L.P at Biotechnology Value Fund. One other person in the database shares a firm with Thor Nagel.
How do I contact Thor Nagel?
A LinkedIn page is on file for Thor Nagel. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal